US Patent 11052087 Anti-HIV compounds

Patent 11052087 was granted and assigned to Gilead Sciences on July, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Gilead Sciences

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11052087

Date of Patent

July 6, 2021

Patent Application Number

16525203

Date Filed

July 29, 2019

Patent Citations

‌

US Patent 10294234 HIV inhibitor compounds

‌

US Patent 10752636 HIV inhibitor compounds

Patent Primary Examiner

‌

Rebecca L Anderson

Patent abstract

The invention provides compounds having Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11052087 Anti-HIV compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API